+499.5%
MRNA vs VEEV
+2.5%
+496.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | VEEV | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.3% | +1.0% | -0.7% |
| 7D | +5.5% | -0.6% | +6.1% | +5.6% |
| 30D | +158.7% | +28.8% | +129.9% | +136.2% |
| 3M | +182.1% | +54.0% | +128.1% | +145.7% |
| 6M | +151.8% | +46.0% | +105.9% | +124.6% |
| YTD | +393.6% | +23.2% | +370.3% | +353.5% |
| 1Y | +499.5% | +1.9% | +497.6% | +449.0% |
| All | +499.5% | +2.5% | +496.9% | +449.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VEEV.
Daily Out/Under-Performance
Portfolio return minus VEEV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VEEV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded VEEV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling